WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Update

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) saw a large growth in short interest in the month of June. As of June 30th, there was short interest totaling 116,931 shares, a growth of 79.6% from the June 15th total of 65,100 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 145,649 shares, the short-interest ratio is presently 0.8 days.

WuXi Biologics (Cayman) Trading Down 2.5%

Shares of WXXWY stock opened at $9.86 on Friday. The stock has a fifty day simple moving average of $8.53 and a two-hundred day simple moving average of $9.01. WuXi Biologics has a 52-week low of $6.85 and a 52-week high of $11.21.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.